Latest News & Features
Americas
The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira. 16 June 2020
article
Discussions around artificial intelligence (AI) and IP can sometimes be futuristic and trapped at the level of high-concept: whether machines can be inventors, for example. But at BIO Digital 2020, a panel of experts was on hand to provide a much more practical, down-to-earth guide to patenting AI inventions. 16 June 2020
Asia-Pacific
Swiss healthcare company Roche has partnered with Chinese biotech Innovent Biologics to develop cell therapies and bispecific antibodies. 15 June 2020
Europe
The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said. 11 June 2020
Americas
A coalition of attorneys general have taken 26 drugmakers, including Pfizer, Sandoz and Mylan, to court over the alleged price-fixing of topical generic drugs. 11 June 2020
Biotechnology
For a start-up looking to build a patent portfolio, where should you start—‘home-grown’ patents, or licensing others’ IP? 11 June 2020
Americas
Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives. 9 June 2020
Big Pharma
Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA. 9 June 2020
Americas
The US Court of Appeals for the Federal Circuit has said it cannot award attorneys’ fees for proceedings before the US Patent Trial and Appeal Board. 5 June 2020
Big Pharma
The COVID-19 pandemic has seen the fundamental principles of the IP system called into question. How can we go on as before? 5 June 2020